|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:1158-1165
© 2004 The American Association for Thoracic Surgery
Surgery for acquired cardiovascular disease |
a Institute for Clinical Evaluative Sciences Toronto, Ontario, Canada
b Division of Cardiovascular Surgery, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada
c Division of General Internal Medicine, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada
Read in part at the 56th annual Canadian Cardiovascular Congress, Toronto, Ontario, Canada, October 24-29, 2003, and the American Heart Association Scientific Sessions 2003, Orlando, Fla, November 9-12, 2003.
Received for publication September 10, 2003; revisions received December 1, 2003; accepted for publication December 9, 2003.
* Address for reprints: Veena Guru, MD, Institute for Clinical Evaluative Sciences, 2075 Bayview Ave, G106, Toronto, Ontario M4N 3M5, Canada
veena.guru{at}utoronto.ca
| Abstract |
|---|
|
|
|---|
METHODS: This was a retrospective cohort study (n = 54,425 patients, 12,079 women) using clinical data for all patients who underwent isolated coronary artery bypass graft surgery in Ontario between fiscal years 1991 and 1999 obtained from the Cardiac Care Network database, with outcomes of early (
1 year) and late (>1 year up to 10 years) interval mortality identified through linkage to administrative databases.
RESULTS: Female surgical candidates were older (65 vs 62 years, P < .0001) and higher-risk patients. The risk-adjusted survival of female patients was worse than that of male patients in the first year after coronary artery bypass graft surgery, but their long-term mortality was similar to that of male patients. The Cox proportional hazards model for early mortality had an adjusted female hazard ratio of 1.44 (95% confidence interval, 1.29-1.61; P = .02). This significantly differed from the late mortality model, which had a hazard ratio of 0.89 (95% confidence interval, 0.78-1.0; P = .06).
CONCLUSIONS: Early mortality was significantly higher for women after coronary artery bypass graft surgery, despite adjustment for confounding factors. However, the long-term relative mortality risk for women appeared equivalent to or even better than that experienced by men as early as 1 year after coronary artery bypass graft surgery. This population-based study of long-term mortality supports the benefits of coronary artery bypass graft surgery for women in the current era. However, further research is needed to identify ways to reduce early postoperative mortality in women.
This difference in mortality has been explained by the fact that female CABG surgery candidates frequently present with older age, smaller body size, smaller coronary arteries, more urgent status, and more comorbid factors than their male counterparts.1,2,9,11,17 The difference in outcomes experienced by women after CABG surgery could also be related to delayed referral or a different pathogenesis of the progression in coronary atherosclerosis.8,18,19 It is also not clear whether graft patency is worse for female patients.12,20 It is known that women are less likely to receive internal thoracic artery (ITA) grafts because of small ITA size, as well as concerns with sternal healing.2,6 Women are less likely to receive complete revascularization, and this might be in part because of their smaller coronary artery size and pattern of disease.6 This all greatly affects their early mortality, even with extensive risk adjustment, and likely also has a significant effect on their late mortality after CABG surgery.
There is less known about the long-term result after coronary surgery in women. There is some evidence to suggest that between 5 and 6 years after CABG surgery, the results are the same or might be better for female patients, with odds ratios (ORs) for late death of between 0.4 and 1 as compared to male patients.7,10,14,15,21-23 This is demonstrated by a population-based study from the city of Stockholm in Sweden involving 2 institutions with 607 women and 3326 men, which revealed the 5-year mortality risk to be equivalent between sexes for patients operated on between 1980 and 1989.15 The reason behind the trend toward improved long-term survival for women compared with men is not known. It might simply be a result of the fact that women have a later onset of their cardiovascular disease and survive longer in the general population. The original studies that demonstrated the long-term benefits of CABG surgery, namely the Coronary Artery Surgery Study and Bypass Angioplasty Revascularization Investigation had only a minority of women. These studies were conducted in a previous era with highly selected patients who are not representative of the current population of patients undergoing CABG. Unfortunately, the evidence behind the long-term survival benefits of CABG surgery for women is not as robust as it is for men.1,22
The purpose of this study is to evaluate mortality between women and men both early and late after CABG surgery by using large population-based clinical and administrative databases in the province of Ontario.
| Methods |
|---|
|
|
|---|
Data linkage
The patients were linked to 3 administrative databases for further clinical information by using unique encrypted identifiers, such as in-hospital and out-of-hospital death. The 3 databases included the Canadian Institute for Health Information database, the Registered Persons Database, and the Ontario Health Insurance Plan database. The Registered Persons Database registers the deaths of all persons residing in Ontario and has been validated against the Canadian Institute for Health Information database for in-hospital deaths. The Ontario Health Insurance Plan database includes the claims submitted by all cardiac surgeons for reimbursement for provided services. Socioeconomic status was determined from linkage of the postal code of each patient (Enumeration Area) to the 1996 Canadian Census database by which each patient's income quintile is designated on the basis of their primary residence. For patients who did not have a Canadian postal code listed, these data were not available. Data for 1991 were only available from September 1 onward but otherwise were analyzed on a fiscal year basis (April 1 of the year to March 31 of the subsequent year).
Data analysis
Separate prediction models for male and female sex and early and late mortality were constructed to identify any obvious covariate interactions. The primary outcomes assessed included early interval mortality (30 days to 1 year) and late interval mortality at different time points (>1 year to 10 years). A Kaplan-Meier curve was constructed by sex for the entire cohort to describe mortality after CABG surgery. A Kaplan-Meier curve was also constructed by sex for comparison with an age-matched sample of the general population.
Cox proportional hazards models were used to adjust mortality for men and women for the entire cohort by using tailored risk adjustment with previously validated variables.24,25 The variables included in the risk adjustment models were as follows: age, Charlson comorbidity score, urgency status, previous CABG surgery, congestive heart failure, left ventricular grade, era of operation, recent preoperative myocardial infarction, previous CABG surgery, history of preoperative stroke, peripheral vascular disease, and surgical coronary artery anatomy. The assumption of proportionality for Cox hazards analysis was tested by using a sex versus duration to death or follow-up time covariate. Because this assumption was violated, separate early mortality (
1 year) and late mortality (>1 year) Cox models were created. The late mortality model was created on the cohort described, excluding those patients who died before or at 1 year after the operation. Other variables added to the risk-adjustment model included use of an ITA, socioeconomic status (available for n = 53,702), and body surface area (BSA; available for subgroup of cohort [1998-1999], n = 13,921). Risk-adjusted survival curves were constructed by sex.
Stepwise logistic regression models were developed to determine the risk-adjusted OR for female interval mortality at various time points (30 days, 31 days to 1 year, >1 year to 2 years, >2 years to 4 years, >4 years to 8 years, and >8 years to 10 years) by using subgroups of patients who survived to this time point and who had similar follow-up, depending on their operative date. Through this method, we were able to isolate the time point at which the mortality risk for female sex changed from the early to late time periods after the operation. Lack-of-fit statistics were optimized for all logistic models constructed, including the c statistic (area under the receiver operator curve) and the Hosmer-Lemeshow statistic, for adequate discrimination and calibration of the models. The c statistic is as follows for each logistic mortality model: 30 days, 0.78; 1 year, 0.77; 2 years, 0.70; 4 years, 0.69; 8 years, 0.71; and 10 years, 0.72. The adjusted 30-day death rates for each sex by fiscal year, left ventricular grade, triage status, Canadian Cardiovascular Society (CCS) angina class, and age were also analyzed. These adjusted mortality rates (in percentages) were calculated by multiplying the observed to expected death ratio by the average death rate in the cohort for various subgroups. The expected death was calculated by using 30-day mortality logistic regression models (excluding the variable being compared). The statistical analyses were completed with SAS software (version 8.2; SAS Institute Inc, Cary, NC).
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Women tend to be higher-risk operative candidates, and this difference in mortality is larger for those female patients who were elderly or had unstable symptoms. The risk-adjusted OR for mortality among female patients is no different than one at 1 year after CABG surgery and remains this way until 10 years after the operation. At 4 years after the operation, the absolute mortality rate for female patients becomes similar to that for male patients, as seen by overlapping risk-adjusted survival curves (Figure 4). The crude survival for both sexes after CABG surgery was worse than that of the age-matched general population. Female patients undergoing CABG had a much larger disparity than their male counterparts to age-matched control subjects both for early and late crude survival.
The proportion of women operated on in our cohort was 22%, and this is comparable with population-based US samples, which have ranged between 24% and 28%. There have been concerns that women compose a minority of surgical patients because fewer are referred for surgical intervention. However, many studies have shown that after their eligibility for an operation is determined through angiography, no female referral bias exists if the analysis includes proper risk adjustment.27-29 We found that the risk-adjusted 30-day mortality improved over the 1990s, likely because of improved surgical techniques for both sexes. This has also been reported by the Northern New England group.16 Our observation that early mortality was higher for female patients might have been an artifact of delayed referral or because female patients are older as a result of delayed onset of cardiovascular disease.22 It was surprising to observe that female patients persisted to have a higher early mortality in the current era with improved surgical techniques, despite using what is recognized to be comprehensive risk adjustment.24
Adjustment models were constructed on subcohorts of patients for whom more data were available to explore this higher early mortality among female patients further. One of these variables, socioeconomic status, a known risk factor for lesser access to cardiac care in Ontario, was used for risk adjustment in the Cox mortality models.30 Women were observed to have a significantly lower socioeconomic status than men. Risk adjustment for socioeconomic status on the patients with this information available (n = 53,702) lowered the early 1-year mortality risk (HR decreased from 1.4 to 1.2) for women. We further risk adjusted for BSA on the subcohort with this variable available (n = 13,921) and found women no longer had a higher early mortality risk compared with men. Women tended to have a lower body size, although their distribution of BSA values did overlap with that of men. In view of this fact, the neutralization of early mortality by adjustment with BSA might have occurred partially because BSA served as a surrogate marker for sex. There have been conflicting results in the literature regarding whether a higher early mortality risk for female patients remains after adjusting for BSA.2,5,11,15 In summary, a smaller subcohort of our study demonstrates that small BSA appears to explain the higher early mortality risk for female patients. It is evident that this early aspect of female outcomes still requires further investigation, including the evaluation of both biochemical and clinical factors that might help to explain this difference.
In contrast, the risk-adjusted odds for late mortality among female patients appeared equivalent to that of male patients as soon as 1 year after CABG surgery. The previous studies looking at long-term mortality involved post hoc analyses of trials data on patients who were highly selected with discrete inclusion criteria.21,22 These studies had patient samples that are not comparable with the older and sicker patients currently referred for CABG surgery.21,22 The long-term results of our study are similar to those reported by the Bypass Angioplasty Revascularization Investigation and Coronary Artery Surgery Study trials at 5 to 6 years after surgical intervention.21,22 This is surprising considering it still appears that women are higher-risk patients who probably receive fewer arterial grafts with less complete revascularization. In our cohort women were less likely to receive an ITA graft compared with men (70% of female patients vs 79% of male patients, P < .0001). However, when adjustments were made for ITA use, it did not change the early or late mortality risk for female sex. After we adjusted long-term mortality for socioeconomic status, we found that female sex became a significant protective factor (HR, 0.94; 95% CI, 0.88-1.00; P = .04).
One of the limitations of our study is that we did not have detailed operative data on factors that might have differed for female patients, including coronary artery size and completeness of revascularization. This type of detailed clinical information could have helped to explain the higher early mortality risk experienced by women. Furthermore, other adverse outcomes, such as nonfatal cardiac events, neurologic complications, or renal insufficiency, might differ significantly after CABG surgery, and we hope to explore these questions in future research.
Our study is unique in using interval mortality in the construction of our regression models rather than cumulative mortality. This approach allowed for tailored assessment with clinical data of those patients who survived to the time interval of interest. Other strengths include the large size of our sample, which included the entire population of Ontario patients undergoing CABG and the fact that our study was conducted in the current era, with accurate long-term follow-up.
From our population of patients undergoing CABG, it appears that women might have a persistently higher early mortality in current times but have an excellent late outcome after CABG surgery. In fact, after further adjustment for socioeconomic status, female sex might be a protective factor for long-term survival. Although the long-term benefits of CABG surgery in women are clear, further study is needed to explore ways to reduce mortality in the perioperative period and during the first year after the operation, particularly in the patients at highest risk, such as those with the lowest socioeconomic status.
| Acknowledgments |
|---|
| Footnotes |
|---|
Dr Guru is supported by a salary fellowship for the Canadian Institutes of Health Research (CIHR) and a grant from the Tanna-Schulich fellowship fund of Sunnybrook and Women's College Health Sciences Centre. Dr Tu is supported by a Canada Research Chair in Health Services Research and through a grant for the Canadian Cardiovascular Outcomes Research Team (www.ccort.ca) from the CIHR and the Heart and Stroke Foundation of Canada.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Naughton, R. O. Feneck, and J. Roxburgh Early and late predictors of mortality following on-pump coronary artery bypass graft surgery in the elderly as compared to a younger population Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 621 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C Ennker, A. Albert, D. Pietrowski, K. Bauer, J. Ennker, and I. Florath Impact of Gender on Outcome After Coronary Artery Bypass Surgery Asian Cardiovasc Thorac Ann, June 1, 2009; 17(3): 253 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Singh-Manoux, A. Gueguen, J. Ferrie, M. Shipley, P. Martikainen, S. Bonenfant, M. Goldberg, and M. Marmot Gender Differences in the Association Between Morbidity and Mortality Among Middle-Aged Men and Women Am J Public Health, December 1, 2008; 98(12): 2251 - 2257. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Koch Con: Newly Appreciated Pathophysiology of Ischemic Heart Disease in Women Mandates Changes in Perioperative Management Anesth. Analg., July 1, 2008; 107(1): 33 - 36. [Full Text] [PDF] |
||||
![]() |
V. Guru, J. V. Tu, E. Etchells, G. M. Anderson, C. D. Naylor, R. J. Novick, C. M. Feindel, F. D. Rubens, K. Teoh, A. Mathur, et al. Relationship Between Preventability of Death After Coronary Artery Bypass Graft Surgery and All-Cause Risk-Adjusted Mortality Rates Circulation, June 10, 2008; 117(23): 2969 - 2976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ranucci, A. Pazzaglia, C. Bianchini, G. Bozzetti, and G. Isgro Body Size, Gender, and Transfusions as Determinants of Outcome After Coronary Operations Ann. Thorac. Surg., February 1, 2008; 85(2): 481 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Humphries, M. Gao, A. Pu, S. Lichtenstein, and C. R. Thompson Significant Improvement in Short-Term Mortality in Women Undergoing Coronary Artery Bypass Surgery (1991 to 2004) J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1552 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pilote, K. Dasgupta, V. Guru, K. H. Humphries, J. McGrath, C. Norris, D. Rabi, J. Tremblay, A. Alamian, T. Barnett, et al. A comprehensive view of sex-specific issues related to cardiovascular disease Can. Med. Assoc. J., March 13, 2007; 176(6): S1 - S44. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Nussmeier Are women different from men in ways that matter? Maybe J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 264 - 265. [Full Text] [PDF] |
||||
![]() |
I. K. Toumpoulis, C. E. Anagnostopoulos, S. K. Balaram, C. K. Rokkas, D. G. Swistel, R. C. Ashton Jr, and J. J. DeRose Jr Assessment of independent predictors for long-term mortality between women and men after coronary artery bypass grafting: Are women different from men? J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 343 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Guru, S. E. Fremes, P. C. Austin, E. H. Blackstone, and J. V. Tu Gender Differences in Outcomes After Hospital Discharge From Coronary Artery Bypass Grafting Circulation, January 31, 2006; 113(4): 507 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Habib, A. Zacharias, T. A. Schwann, C. J. Riordan, S. J. Durham, and A. Shah Effects of Obesity and Small Body Size on Operative and Long-Term Outcomes of Coronary Artery Bypass Surgery: A Propensity-Matched Analysis Ann. Thorac. Surg., June 1, 2005; 79(6): 1976 - 1986. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Birdas, J. T. Landis, D. Haybron, D. Evers, P. K. Papasavas, and P. F. Caushaj Outcomes of Coronary Artery Bypass Grafting in Patients With Connective Tissue Diseases Ann. Thorac. Surg., May 1, 2005; 79(5): 1610 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Fox and N. A. Nussmeier Does Gender Influence the Likelihood or Types of Complications Following Cardiac Surgery? Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 283 - 295. [Abstract] [PDF] |
||||
![]() |
R. H. Habib, A. Zacharias, T. A. Schwann, C. J. Riordan, S. J. Durham, and A. Shah Worse early outcomes in women after coronary artery bypass grafting: Is it simply a matter of size? J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 487 - 488. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |